28.07.2022 22:23:24
|
Edwards Lifesciences Corp. Q2 Profit Decreases, misses estimates
(RTTNews) - Edwards Lifesciences Corp. (EW) revealed a profit for second quarter that decreased from the same period last year and missed the Street estimates.
The company's earnings came in at $406.4 million, or $0.65 per share. This compares with $489.5 million, or $0.78 per share, in last year's second quarter.
Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $392.9 million or $0.63 per share for the period.
Analysts on average had expected the company to earn $0.64 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 0.7% to $1.37 billion from $1.38 billion last year.
Edwards Lifesciences Corp. earnings at a glance (GAAP) :
-Earnings (Q2): $406.4 Mln. vs. $489.5 Mln. last year. -EPS (Q2): $0.65 vs. $0.78 last year. -Analyst Estimates: $0.64 -Revenue (Q2): $1.37 Bln vs. $1.38 Bln last year.
-Guidance: Next quarter EPS guidance: $0.58 - $0.66 Next quarter revenue guidance: $1.30 - $1.37 Bln Full year EPS guidance: $2.50 - $2.65 Full year revenue guidance: $5.35 - $5.55 Bln
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Edwards Lifesciences Corp.mehr Nachrichten
Analysen zu Edwards Lifesciences Corp.mehr Analysen
Aktien in diesem Artikel
Edwards Lifesciences Corp. | 69,35 | -0,66% |